Bolt Biotherapeutics Inc. (NASDAQ: BOLT)
$0.74
+0.0064 ( +0.87% ) 97.4K
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Market Data
Open
$0.74
Previous close
$0.73
Volume
97.4K
Market cap
$28.22M
Day range
$0.73 - $0.74
52 week range
$0.71 - $1.56
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 57 | May 14, 2024 |
8-k | 8K-related | 15 | May 14, 2024 |
def | Proxies and info statements | 6 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
10-k | Annual reports | 75 | Mar 21, 2024 |
8-k | 8K-related | 13 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |